Sigma-Aldrich
Spacer
Decrease Font Size Increase Font Size Email this page to a friend Printer Friendly Page
Corporate > Business Development > Out-Licensing Opportunities
Business Development

Out-Licensing Opportunities

 

RNAi Opportunities

Lentiviral delivery technology
Patent (364 Kb PDF)
Sigma-Aldrich Corporation is the exclusive worldwide licensee of U.S. Pat. Nos. 5,817,491; 5,591,624; 5,716,832; 6,312,682; 6,669,936; 6,235,522; 6,924,123 and foreign equivalents from Oxford Biomedica Ltd., Oxford, UK.

DNA-directed RNA interference
Patent (56 Kb PDF)
Sigma-Aldrich Corporation is also the exclusive worldwide licensee for certain fields of U.S. Pat. No. 6,573,099 and foreign counterparts co-owned by Benitec Australia, Ltd. and the Australian Commonwealth Scientific and Industrial Research Organization (CSIRO) both of Australia.

Sigma-Aldrich is making available sublicenses of the licensed patents as well as making available licensed Lentivirus-based shRNA Libraries for purchase through its catalog and web sites.


red_cube For a commercial license to the DNA-directed RNA interference IP, please visit the Benitec Web site.
red_cube For information on research licenses, please contact:
Carl Schrott, carl.schrott@sial.com, Director of Business Development    314-431-0558
Raju Sakaria, raju.sakaria@sial.com, Senior Business Development Manager    +44 1483 722797


FLAG® Opportunities

Multiple Epitopes for Identification and Purification of Recombinant Proteins and
FLAG / ANTI-FLAG Trademarks
Cleavable Multiple-FLAG (DYKDDDDK) epitope-tag expression and purification technology.
Use of FLAG / Anti-FLAG trademarks.
Discovery Tools • Primary Screening
• Secondary Screening (e.g. cell biological profiling or high content screening)
• Target Discovery (proteomic or genomic based)
• Target Validation (proteomic or genomic based)
• Protein Expression
Marketing Rights
Available/Desired
• Worldwide
Publications US Patent 6,379,903 (459 Kb PDF)

 

red_cube For information on research licenses, please contact:
Carl Schrott, carl.schrott@sial.com, Director of Business Development    314-431-0558
Rebecca Poon, rebecca.poon@sial.com, Business Development Manager

 

Back to Top

HIS-Select® Opportunities

HIS-Select Metal Chelate Composition & iLAP™ (Integrated Lysis and Purification) Technologies
HIS-Select technology is a proprietary metal chelate with superior specificity over conventional nitrilotriacetic acid resins. iLAP is combined solid phase cell lysis and purification platform. Both technologies are also trademark registered.
Discovery Tools • Protein Expression
Marketing Rights
Available/Desired
• Worldwide
Publications • Patents: US 7,033,520 (799 Kb PDF); US 6,623,655 (998 Kb PDF);
  US 20060148090 (787 Kb PDF); US 20040092031 (773 Kb PDF);
  US 20040259162 (2.5 Mb PDF)

 

red_cube For information on research licenses, please contact:
Carl Schrott, carl.schrott@sial.com, Director of Business Development    314-431-0558
Rebecca Poon, rebecca.poon@sial.com, Business Development Manager

 

Back to Top

REDTaq® & REDAccuTaq® Opportunities

REDTaq and REDAccuTaq are based on an invention using tracer reagents to enhance PCR and RT-PCR reaction-product analysis enabling simple direct gel loading for visualization.
Discovery Tools • Genomics
Marketing Rights
Available/Desired
• Worldwide
Publications • Relevant patent and patent applications: US 6,942,964 (1.3 Mb PDF);
  US20050148009 (1.2 Mb PDF); US20050148010 (1.2 Mb PDF);
  US20050148011 (1.2 Mb PDF). REDTaq and REDAccuTaq are registered
  trademarks of Sigma-Aldrich

 

red_cube For information on research licenses, please contact:
Carl Schrott, carl.schrott@sial.com, Director of Business Development    314-431-0558
Rebecca Poon, rebecca.poon@sial.com, Business Development Manager

 

Back to Top

Whole Genome Amplification Opportunities

Whole Genome Amplification Technology
Discovery Tools • Pharmacogenetics/genomics
Marketing Rights
Available/Desired
• Worldwide
Field of use restriction • Research use and service providers
Publications US Patent Application No. 10/795,667 (7.2 Mb PDF)
  International Application No. PCT/US204/00693 Titled "Amplification and
  Analysis of Whole Genome and Whole Transcriptome Libraries Generated
  by a DNA Polymerization Process"

 

red_cube For information on research licenses, please contact:
Carl Schrott, carl.schrott@sial.com, Director of Business Development    314-431-0558
Rebecca Poon, rebecca.poon@sial.com, Business Development Manager

 

Back to Top

Whole Transcriptome Amplification Opportunities

Whole Transcriptome Amplification Technology
Discovery Tools • Pharmacogenetics/genomics
Marketing Rights
Available/Desired
• Worldwide
Field of use restriction • Research use and service providers
Publications US Patent Application No. 10/795,667 (7.2 Mb PDF)
  International Application No. PCT/US204/00693 Titled "Amplification and
  Analysis of Whole Genome and Whole Transcriptome Libraries Generated
  by a DNA Polymerization Process"

 

red_cube For information on research licenses, please contact:
Carl Schrott, carl.schrott@sial.com, Director of Business Development    314-431-0558
Rebecca Poon, rebecca.poon@sial.com, Business Development Manager

 

Back to Top

Chemistry Opportunities

Borane-Sulfide Hydroboration Agents
US Patent 5567849 (465 Kb PDF)

Dioxane-Monochloroborane and Dioxane-Dichloroborane
US Patent 6008414 (386 Kb PDF)

Stabilized Borane-Tetrahydrofuran Complex
US Patent WO06020639A2 (1.81 Mb PDF)


red_cube For more information, please contact:
Nate Wallock, nate.wallock@sial.com, Technology Transfer Manager    414-438-5134
Ilya Koltover, ilya.koltover@sial.com, Business Development Manager, Chemistry    414-438-3842

 
 

Back to Top
Back to Business Development